Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M109,030Revenue $M18,135Net Margin (%)21.0Altman Z-Score1.2
Enterprise Value $M152,543EPS $7.9Operating Margin %-13.6Piotroski F-Score6
P/E(ttm)33.8Beneish M-Score-2.5Pre-tax Margin (%)-20.5Higher ROA y-yY
Price/Book1.510-y EBITDA Growth Rate %--Quick Ratio1.9Cash flow > EarningsN
Price/Sales4.95-y EBITDA Growth Rate %3.8Current Ratio2.1Lower Leverage y-yY
Price/Free Cash Flow28.1y-y EBITDA Growth Rate %-22.6ROA % (ttm)3.6Higher Current Ratio y-yY
Dividend Yield %0.1PEG--ROE % (ttm)6.6Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M394ROIC % (ttm)-1.8Gross Margin Increase y-yY

Gurus Latest Trades with AGN

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
AGNVanguard Health Care Fund 2015-12-31 Add1.1%$253.04 - $322.49
($298.52)
$ 266.30-11%Add 19.27%10,962,347
AGNKen Fisher 2015-12-31 Add$253.04 - $322.49
($297.97)
$ 266.30-11%Add 3.80%3,306
AGNMario Gabelli 2015-12-31 Add$253.04 - $322.49
($298.52)
$ 266.30-11%Add 5.06%33,473
AGNGeorge Soros 2015-09-30 Add2.86%$252.1 - $339.5
($307.17)
$ 266.30-13%Add 386.12%774,566
AGNWallace Weitz 2015-09-30 Buy 1.6%$252.1 - $339.5
($307.17)
$ 266.30-13%New holding187,607
AGNRuane Cunniff 2015-09-30 Buy 1.54%$252.1 - $339.5
($307.17)
$ 266.30-13%New holding1,103,395
AGNJulian Robertson 2015-09-30 Add0.55%$252.1 - $339.5
($307.17)
$ 266.30-13%Add 34.16%59,700
AGNLeon Cooperman 2015-09-30 Reduce-0.54%$252.1 - $339.5
($307.17)
$ 266.30-13%Reduce -12.01%811,635
AGNSteve Mandel 2015-09-30 Add0.36%$252.1 - $339.5
($307.17)
$ 266.30-13%Add 13.48%2,607,655
AGNPrivate Capital 2015-09-30 Add0.12%$252.1 - $339.5
($307.17)
$ 266.30-13%Add 2.23%169,620
AGNVanguard Health Care Fund 2015-09-30 Add0.09%$252.1 - $339.5
($307.17)
$ 266.30-13%Add 1.69%9,190,927
AGNFirst Eagle Investment 2015-09-30 Add0.09%$252.1 - $339.5
($307.17)
$ 266.30-13%Add 8.07%1,671,156
AGNJohn Paulson 2015-09-30 Add0.01%$252.1 - $339.5
($307.17)
$ 266.30-13%Add 0.11%7,182,000
AGNMario Gabelli 2015-09-30 Reduce-0.01%$252.1 - $339.5
($307.17)
$ 266.30-13%Reduce -14.55%31,862
AGNKen Fisher 2015-09-30 Reduce$252.1 - $339.5
($307.17)
$ 266.30-13%Reduce -11.03%3,185
AGNDodge & Cox 2015-09-30 Reduce$252.1 - $339.5
($307.17)
$ 266.30-13%Reduce -31.29%1,100
AGNJohn Keeley 2015-09-30 Sold Out $252.1 - $339.5
($307.17)
$ 266.30-13%Sold Out0
AGNJohn Paulson 2015-06-30 Add2.21%$282.86 - $313.08
($298.2)
$ 266.30-11%Add 27.18%7,174,200
AGNJulian Robertson 2015-06-30 Reduce-1.4%$282.86 - $313.08
($298.2)
$ 266.30-11%Reduce -38.62%44,500
AGNGeorge Soros 2015-06-30 Reduce-0.85%$282.86 - $313.08
($298.2)
$ 266.30-11%Reduce -61.82%159,338
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

AGN is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


AGN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Basgoz NesliDirector 2015-12-07Sell2,300$312.96-14.91view
BISARO PAULExec Chairman 2015-08-24Buy1,000$297.42-10.46view
SAUNDERS BRENT LCEO and President 2015-08-21Buy1,000$301.94-11.8view
Basgoz NesliDirector 2015-06-09Sell2,200$297.89-10.6view
Meury WilliamSee Remarks 2014-11-26Sell4,550$269.14-1.06view
PAONESSA ALBERT IIIPresident Anda, Inc. 2014-09-08Sell6,642$230.4915.54view
Hindman James M.EVP, Finance & Bus. Dev., CFO 2014-08-18Sell0$015.54view
Sherman Scott DExecutive Vice President, HR 2014-04-22Sell14,500$155.8270.9view
LAVIGNE LOUIS J JRDirector 2014-02-21Sell5,400$125.79111.7view
INGRAM DOUGLAS SPresident 2014-02-21Sell1$125.7111.85view

Press Releases about AGN :

Quarterly/Annual Reports about AGN:

    News about AGN:

    Articles On GuruFocus.com
    Vanguard Health Care Fund Sells Stake in Humana Feb 03 2016 
    Bill Ackman’s Fund Falls by Double Digits Again in January Feb 02 2016 
    Baron Funds Comments on Allergan Jan 27 2016 
    Bill Ackman's Pershing Square Annual Investor Letter Jan 27 2016 
    Dalio, Tepper, Klarman Ranked Best Hedge Fund Managers Jan 26 2016 
    Weitz Funds Comments on Allergan Jan 25 2016 
    Wallace Weitz Comments on Allergan Jan 22 2016 
    2 Stocks Super Investors Are Buying in Large Quantities Dec 26 2015 
    5 Top Stocks of the Outperforming Vanguard Health Care Fund Dec 28 2015 
    5 Guru Picks in Volatile Biotech Industry Dec 23 2015 

    More From Other Websites
    Pfizer To Reorganize After Allergan Buyout, With Saunders President Feb 08 2016
    Pfizer unveils management line up for combined company Feb 08 2016
    Pfizer unveils management line up for combined company Feb 08 2016
    [$$] Pfizer Outlines Post-Merger Management Slate Feb 08 2016
    Pfizer Names New Executives to Run Units After Allergan Deal Feb 08 2016
    Pfizer to create operating unit after Allergan deal closes Feb 08 2016
    Pfizer Names Executive Leadership Team for Combined Organization Upon Close of Proposed Allergan... Feb 08 2016
    Pfizer Names Executive Leadership Team for Combined Organization Upon Close of Proposed Allergan... Feb 08 2016
    Pfizer's Pipeline Productivity Is Improving Feb 05 2016
    Momentum, Strategy within Today's Market - Analyst Notes on Gilead Sciences, Schlumberger, Royal... Feb 04 2016
    [$$] Pfizer Beats Expectations but Guidance Disappoints Feb 02 2016
    Pfizer Looks Undervalued Feb 02 2016
    [$$] Pfizer says US politicians will not scupper Allergan deal Feb 02 2016
    Pfizer 2016 forecast disappoints Feb 02 2016
    Pfizer earnings fall but tops Street 4Q forecasts Feb 02 2016
    Pfizer earnings fall but tops Street 4Q forecasts Feb 02 2016
    Pfizer earnings fall on strong dollar, higher expenses Feb 02 2016
    Pfizer Beats on Q4 Earnings, Revenues, Outlook Disappoints Feb 02 2016
    Pfizer forecasts 2016 revenue, earnings below estimates Feb 02 2016
    Jim Cramer: Stop Thinking So Short Term About Biotech Stocks Feb 01 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK